The Effect of Intraoperative Dexmedetomidine on Renal Function After Coronary Artery Bypass Graft Surgery
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY
This is a prospective randomized clinical trial designed to determine the effect of intraoperative dexmedetomidine administration on renal function after coronary artery bypass graft surgery.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Elective coronary artery bypass graft surgery
• Age over 18 years
• ASA score 3 or 4
• Voluntary consent of the patient to participate in the research
Locations
Other Locations
Serbia
University of Novi Sad, Faculty of Medicine
RECRUITING
Novi Sad
Contact Information
Primary
Ranko Zdravkovic
ranko.zdravkovic@mf.uns.ac.rs
+381654674620
Time Frame
Start Date: 2024-04-03
Estimated Completion Date: 2024-10
Participants
Target number of participants: 100
Treatments
Experimental: Experimental
Patients from the experimental group will receive a continuous infusion of dexmedetomidine at a dose of 0.5 µg/kg/h, until the end of the operation.
Placebo_comparator: Control
Patients in the control group will receive the same volume of saline solution.
Related Therapeutic Areas
Sponsors
Leads: University of Novi Sad